Analysis of human V-erbA related EAR-3 gene expression between transitional cell carcinoma and normal tissue in bladder cancer

Won Sik Han, Joo Hyoung Lee, Ho Song Yu, Young Deuk Choi

Research output: Contribution to journalArticle

Abstract

Purpose: The prognosis of bladder cancer is related to tumor grade and stage. Because these pathological changes are preceded by molecular alterations, new molecular markers are needed in early diagnosis. New target molecular biomarkers can be differentially expressed genes (DEGs) between normal and cancer tissues. We tried to find a new DEG and demonstrated that it may be related to the development of the bladder cancer. Materials and methods: Cancer tissues were obtained from 39 patients with urothelial cell carcinoma, treated by transurethral resection of tumor (TURB) since 2002. Normal bladder tissues were obtained from the same patients during TURB. We compared the mRNA profiles between normal and cancer tissues using annealing control primer (ACP)-based Genefishing™ PCR to identify the DEGs in normal and cancer tissues of one same patient. To validate the result of ACP-based GeneFishing™ PCR, reverse transcription-polymerase chain reaction (RT-PCR) was performed on those of 39 patients. Results: According to the result of ACP-based Genefishing™ PCR, EAR-3 gene was only present or markedly upregulated in normal tissue, compared with cancer tissues. The expression pattern that EAR-3 gene was downregulated in cancer tissues, irrespective of the clinicopathologic parameters was confirmed by RT-PCR in 39 patients. Conclusions: EAR-3 gene was downregulated in cancer tissues, irrespective of clinicopathologic parameters, compared with normal tissues in the bladder of the same patient. Therefore, we suggested that EAR-3 gene may be also play a role in bladder cancer development.

Original languageEnglish
Pages (from-to)915-920
Number of pages6
JournalKorean Journal of Urology
Volume48
Issue number9
Publication statusPublished - 2007 Sep 1

Fingerprint

Transitional Cell Carcinoma
Urinary Bladder Neoplasms
Gene Expression
Neoplasms
Genes
Polymerase Chain Reaction
Reverse Transcription
Urinary Bladder
Down-Regulation
Early Diagnosis
Biomarkers
Carcinoma
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

@article{cf5167ff61dc423f92dbf6d9884cf619,
title = "Analysis of human V-erbA related EAR-3 gene expression between transitional cell carcinoma and normal tissue in bladder cancer",
abstract = "Purpose: The prognosis of bladder cancer is related to tumor grade and stage. Because these pathological changes are preceded by molecular alterations, new molecular markers are needed in early diagnosis. New target molecular biomarkers can be differentially expressed genes (DEGs) between normal and cancer tissues. We tried to find a new DEG and demonstrated that it may be related to the development of the bladder cancer. Materials and methods: Cancer tissues were obtained from 39 patients with urothelial cell carcinoma, treated by transurethral resection of tumor (TURB) since 2002. Normal bladder tissues were obtained from the same patients during TURB. We compared the mRNA profiles between normal and cancer tissues using annealing control primer (ACP)-based Genefishing™ PCR to identify the DEGs in normal and cancer tissues of one same patient. To validate the result of ACP-based GeneFishing™ PCR, reverse transcription-polymerase chain reaction (RT-PCR) was performed on those of 39 patients. Results: According to the result of ACP-based Genefishing™ PCR, EAR-3 gene was only present or markedly upregulated in normal tissue, compared with cancer tissues. The expression pattern that EAR-3 gene was downregulated in cancer tissues, irrespective of the clinicopathologic parameters was confirmed by RT-PCR in 39 patients. Conclusions: EAR-3 gene was downregulated in cancer tissues, irrespective of clinicopathologic parameters, compared with normal tissues in the bladder of the same patient. Therefore, we suggested that EAR-3 gene may be also play a role in bladder cancer development.",
author = "Han, {Won Sik} and Lee, {Joo Hyoung} and Yu, {Ho Song} and Choi, {Young Deuk}",
year = "2007",
month = "9",
day = "1",
language = "English",
volume = "48",
pages = "915--920",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "9",

}

Analysis of human V-erbA related EAR-3 gene expression between transitional cell carcinoma and normal tissue in bladder cancer. / Han, Won Sik; Lee, Joo Hyoung; Yu, Ho Song; Choi, Young Deuk.

In: Korean Journal of Urology, Vol. 48, No. 9, 01.09.2007, p. 915-920.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of human V-erbA related EAR-3 gene expression between transitional cell carcinoma and normal tissue in bladder cancer

AU - Han, Won Sik

AU - Lee, Joo Hyoung

AU - Yu, Ho Song

AU - Choi, Young Deuk

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Purpose: The prognosis of bladder cancer is related to tumor grade and stage. Because these pathological changes are preceded by molecular alterations, new molecular markers are needed in early diagnosis. New target molecular biomarkers can be differentially expressed genes (DEGs) between normal and cancer tissues. We tried to find a new DEG and demonstrated that it may be related to the development of the bladder cancer. Materials and methods: Cancer tissues were obtained from 39 patients with urothelial cell carcinoma, treated by transurethral resection of tumor (TURB) since 2002. Normal bladder tissues were obtained from the same patients during TURB. We compared the mRNA profiles between normal and cancer tissues using annealing control primer (ACP)-based Genefishing™ PCR to identify the DEGs in normal and cancer tissues of one same patient. To validate the result of ACP-based GeneFishing™ PCR, reverse transcription-polymerase chain reaction (RT-PCR) was performed on those of 39 patients. Results: According to the result of ACP-based Genefishing™ PCR, EAR-3 gene was only present or markedly upregulated in normal tissue, compared with cancer tissues. The expression pattern that EAR-3 gene was downregulated in cancer tissues, irrespective of the clinicopathologic parameters was confirmed by RT-PCR in 39 patients. Conclusions: EAR-3 gene was downregulated in cancer tissues, irrespective of clinicopathologic parameters, compared with normal tissues in the bladder of the same patient. Therefore, we suggested that EAR-3 gene may be also play a role in bladder cancer development.

AB - Purpose: The prognosis of bladder cancer is related to tumor grade and stage. Because these pathological changes are preceded by molecular alterations, new molecular markers are needed in early diagnosis. New target molecular biomarkers can be differentially expressed genes (DEGs) between normal and cancer tissues. We tried to find a new DEG and demonstrated that it may be related to the development of the bladder cancer. Materials and methods: Cancer tissues were obtained from 39 patients with urothelial cell carcinoma, treated by transurethral resection of tumor (TURB) since 2002. Normal bladder tissues were obtained from the same patients during TURB. We compared the mRNA profiles between normal and cancer tissues using annealing control primer (ACP)-based Genefishing™ PCR to identify the DEGs in normal and cancer tissues of one same patient. To validate the result of ACP-based GeneFishing™ PCR, reverse transcription-polymerase chain reaction (RT-PCR) was performed on those of 39 patients. Results: According to the result of ACP-based Genefishing™ PCR, EAR-3 gene was only present or markedly upregulated in normal tissue, compared with cancer tissues. The expression pattern that EAR-3 gene was downregulated in cancer tissues, irrespective of the clinicopathologic parameters was confirmed by RT-PCR in 39 patients. Conclusions: EAR-3 gene was downregulated in cancer tissues, irrespective of clinicopathologic parameters, compared with normal tissues in the bladder of the same patient. Therefore, we suggested that EAR-3 gene may be also play a role in bladder cancer development.

UR - http://www.scopus.com/inward/record.url?scp=34848846559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848846559&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34848846559

VL - 48

SP - 915

EP - 920

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 9

ER -